Japan is the second largest pharmaceutical market in the world and leader in imports of the sector. Japanese life sciences companies are in the process of globalization and need alliances with foreign companies and biotechnology institutions to develop new medicines and incorporate new technologies. To that end, Japan is a strategic market for bioXclusters metacluster alliance. In collaboration with its Japanese Gateway Osaka Bio Headquarters, and with support of the EU-Japan Centre for industrial collaboration, bioXclusters organizes a mission to Japan in October 2017, following the 2016 success.
The organized mission allows to attend the following events.
- BioJapan (11-13 October 2017): Asia-wide benchmark trade fair for the global biotechnology industry that will bring together key business development and licensing professionals, R&D professionals and executives from biotechnology companies. This year’s fair also includes a HealthCare management and digital health area.
- European Biotech & Pharma Partnering Conference (10 October 2017): partnering conference organized by the bioXclusters plus progam in collaboration with EU-Japan Center to be held in Osaka. The meeting will feature B2B meetings with Japanese companies and it takes place at the Congrès Convention Center in Osaka, Japan.
- Regenerative Medicine Japan (11-13 October 2017): BioJapan parallel partnering event focusing on regenerative medicine.
Aforementioned European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for Continue reading